These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 26339057

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
    Tsai YH, Huang SW, Hsieh WS, Cheng CK, Chang CF, Wang YF, Wang JR.
    J Virol; 2019 Jul 01; 93(13):. PubMed ID: 30996087
    [Abstract] [Full Text] [Related]

  • 3. Antigenic mapping of enterovirus A71 from Taiwan and Southeast Asia.
    Cheng D, Huang SW, Tsai YH, Lien YY, Wang JR.
    Antiviral Res; 2023 Apr 01; 212():105569. PubMed ID: 36822369
    [Abstract] [Full Text] [Related]

  • 4. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
    Hsieh W-S, Chao C-H, Shen C-Y, Cheng D, Huang S-W, Wang Y-F, Chen C-C, Chen S-H, Hsu L-J, Wang J-R.
    J Virol; 2024 Jan 23; 98(1):e0155823. PubMed ID: 38174926
    [Abstract] [Full Text] [Related]

  • 5. Immune responses against enterovirus A71 infection: Implications for vaccine success.
    Aw-Yong KL, NikNadia NMN, Tan CW, Sam IC, Chan YF.
    Rev Med Virol; 2019 Sep 23; 29(5):e2073. PubMed ID: 31369184
    [Abstract] [Full Text] [Related]

  • 6. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
    Huang SW, Huang YH, Tsai HP, Kuo PH, Wang SM, Liu CC, Wang JR.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931688
    [Abstract] [Full Text] [Related]

  • 7. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
    Zhang C, Wang Y, Ma S, Li L, Chen L, Yan H, Peng T.
    Viral Immunol; 2016 Jun 01; 29(5):288-95. PubMed ID: 27259043
    [Abstract] [Full Text] [Related]

  • 8. Identification and characterization of neutralization epitopes at VP2 and VP1 of enterovirus A71.
    NikNadia N, Tan CW, Ong KC, Sam IC, Chan YF.
    J Med Virol; 2018 Jun 01; 90(6):1164-1167. PubMed ID: 29457642
    [Abstract] [Full Text] [Related]

  • 9. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
    Yang YT, Chow YH, Hsiao KN, Hu KC, Chiang JR, Wu SC, Chong P, Liu CC.
    Antiviral Res; 2016 Aug 01; 132():225-32. PubMed ID: 27387826
    [Abstract] [Full Text] [Related]

  • 10. Neutralization of African enterovirus A71 genogroups by antibodies to canonical genogroups.
    Volle R, Luo L, Razafindratsimandresy R, Sadeuh-Mba SA, Gouandjika-Valisache I, Horwood P, Duong V, Buchy P, Joffret ML, Huang Z, Duizer E, Martin J, Chakrabarti LA, Dussart P, Jouvenet N, Delpeyroux F, Bessaud M.
    J Gen Virol; 2023 Nov 01; 104(11):. PubMed ID: 37909282
    [Abstract] [Full Text] [Related]

  • 11. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
    Meng T, Wong SM, Chua KB.
    J Virol; 2021 Oct 27; 95(22):e0105521. PubMed ID: 34468173
    [Abstract] [Full Text] [Related]

  • 12. Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan.
    Huang KA, Huang PN, Huang YC, Yang SL, Tsao KC, Chiu CH, Shih SR, Lin TY.
    PLoS Pathog; 2020 Sep 27; 16(9):e1008857. PubMed ID: 32936838
    [Abstract] [Full Text] [Related]

  • 13. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
    Li G, Gao Q, Yuan S, Wang L, Altmeyer R, Lan K, Yin F, Zou G.
    Antiviral Res; 2017 Jul 27; 143():85-96. PubMed ID: 28412182
    [Abstract] [Full Text] [Related]

  • 14. Enterovirus A71 2A-S125A acts as an attenuated vaccine candidate, indicating a universal approach in developing enterovirus vaccines.
    Zhang P, Zou W, Xiong R, Wu Y, Fan C, Peng Y.
    J Med Virol; 2024 Aug 27; 96(8):e29838. PubMed ID: 39081166
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization of enterovirus-A71 in children with acute flaccid paralysis in the Philippines.
    Apostol LN, Shimizu H, Suzuki A, Umami RN, Jiao MMA, Tandoc A, Saito M, Lupisan S, Oshitani H.
    BMC Infect Dis; 2019 May 02; 19(1):370. PubMed ID: 31046684
    [Abstract] [Full Text] [Related]

  • 16. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.
    Hsieh CF, Jheng JR, Lin GH, Chen YL, Ho JY, Liu CJ, Hsu KY, Chen YS, Chan YF, Yu HM, Hsieh PW, Chern JH, Horng JT.
    Emerg Microbes Infect; 2020 Dec 02; 9(1):1194-1205. PubMed ID: 32397909
    [Abstract] [Full Text] [Related]

  • 17. A Polysaccharide Purified From Ganoderma lucidum Acts as a Potent Mucosal Adjuvant That Promotes Protective Immunity Against the Lethal Challenge With Enterovirus A71.
    Lin YL, Shih C, Cheng PY, Chin CL, Liou AT, Lee PY, Chiang BL.
    Front Immunol; 2020 Dec 02; 11():561758. PubMed ID: 33117346
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan.
    Huang LM, Chiu CH, Chiu NC, Lin CY, Li MT, Kuo TY, Weng YJ, Hsieh EF, Tai IC.
    Vaccine; 2019 Mar 22; 37(13):1827-1835. PubMed ID: 30803843
    [Abstract] [Full Text] [Related]

  • 19. Genomic Epidemiology and Phylodynamic Analysis of Enterovirus A71 Reveal Its Transmission Dynamics in Asia.
    Xiao J, Huang K, Lu H, Song Y, Han Z, Zhang M, Li J, Zhou X, Chen J, Yu Q, Yang M, Yan D, Ji T, Yang Q, Zhu S, Xu W, Zhang Y.
    Microbiol Spectr; 2022 Oct 26; 10(5):e0195822. PubMed ID: 36200890
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.